[(1R,2R,3S,4R,5S)-4-(6-amino-2-chloropurin-9-yl)-2,3-dihydroxy-1-bicyclo[3.1.0]hexanyl]methoxy-imidazol-1-ylphosphinic acid
Compound with spectra: 1 NMR
![[(1R,2R,3S,4R,5S)-4-(6-amino-2-chloropurin-9-yl)-2,3-dihydroxy-1-bicyclo[3.1.0]hexanyl]methoxy-imidazol-1-ylphosphinic acid](/api/compound/LfAvLt0ACm9.png?ph=true&h=300&w=458 "[(1R,2R,3S,4R,5S)-4-(6-amino-2-chloropurin-9-yl)-2,3-dihydroxy-1-bicyclo[3.1.0]hexanyl]methoxy-imidazol-1-ylphosphinic acid")
| SpectraBase Compound ID | LfAvLt0ACm9 |
|---|---|
| InChI | InChI=1S/C15H17ClN7O5P/c16-14-20-12(17)8-13(21-14)23(6-19-8)9-7-3-15(7,11(25)10(9)24)4-28-29(26,27)22-2-1-18-5-22/h1-2,5-7,9-11,24-25H,3-4H2,(H,26,27)(H2,17,20,21)/t7-,9-,10+,11+,15+/m1/s1 |
| InChIKey | AQSFNUUOZPGKKE-LCNRAPRPSA-N |
| Mol Weight | 441.77 g/mol |
| Molecular Formula | C15H17ClN7O5P |
| Exact Mass | 441.071731 g/mol |
| Enantiomer InChIKey | AQSFNUUOZPGKKE-KUXIKPSUSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | D2O |
(1'S,2'R,3'S,4'R,5'S)-4-(6-AMINO-2-METHYLTHIOOXY-9H-PURIN-9-YL)-1-[PHOSPHORYLOXYMETHYL]-BICYCLO-[3.1.0]-HEXANE-2,3-DIOL
(1'S,2'R,3'S,4'R,5'S)-4-(6-AMINO-2-METHYLTHIO-9H-PURIN-9-YL)-1-[PHOSPHORYLOXYMETHYL]-BICYCLO-[3.1.0]-HEXANE-2,3-DIOL
(1'-S,2'-R,3'-S,4'-R,5'-S)-4'-(6-AMINO-2-CHLOROPURIN-9-YL)-2',3'-(DIHYDROXY)-1'-(METHYLPHOSPHONIC_ACID)-BICYCLO-[3.1.0]-HEXANE
(1'-S,2'-R,3'-S,4'-R,5'-S)-4'-(6-AMINO-2-CHLOROPURIN-9-YL)-2',3'-(DIHYDROXY)-1'-[(E)-PHOSPHONOETHENYL]-BICYCLO-[3.1.0]-HEXANE
4',6'-O-BENZYLIDENE-1',3'-DI-O-METHYL-2'-DEOXY-2'-(2-AMINO-6-(2-TRIMETHYLSILYLETHOXY)-PURIN-9-YL)-D-ALTROPYRANOSIDE
3-BETA-ACETOXY-16-BETA-[4-(3-TOLYL)-1H-1,2,3-TRIAZOL-1-YLMETHYL]-ANDROST-5-EN-17-BETA-OL
(3R,3aR,9bS)-8-Bromo-1,3-diphenyl-1,3,3a,9b-tetrahydro-2,5-dioxa-4-thia1-aza-cyclopenta[a]naphthalene 4,4-dioxide
(3S,3aS,9bS)-8-Bromo-1,3-diphenyl-2,3,3a,9b-tetrahydro-1H-5-oxa-4-thia-1-aza-cyclopenta[a]naphthalene 4,4-dioxide
4-Azido-3-(5-ethylthio-4-phenyl-4H-1,2,4-triazol-3-yl)-1-(4-methylphenyl)-1H-pyrazol-5-yl)(4-bromophenyl)methanone
9-(1-ethyl-5-methyl-1H-pyrazol-4-yl)-6,6-dimethyl-5,6,7,9-tetrahydro[1,2,4]triazolo[5,1-b]quinazolin-8(4H)-one
| Title | Journal or Book | Year |
|---|---|---|
| Adenine Nucleotide Analogues Locked in a Northern Methanocarba Conformation: Enhanced Stability and Potency as P2Y1 Receptor Agonists | Journal of Medicinal Chemistry | 2002 |